PREVENTION AND TREATMENT OF OTITIS MEDIA USING IgA ENRICHED MILK
AssigneeNestec S.A.
InventorsHarald Bruessow, Nanda De Groot, Marie-Claire Fichot
Life of this patent
Estimating the term…
Abstract
This invention relates to a composition suitable for use in the prevention or treatment of otitis media comprising IgA derived from mature bovine milk and having specificity for at least one of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. The invention further extends to the use of such a composition in the prevention or treatment of otitis media.
Claims17
A composition suitable for use in the prevention or treatment of otitis media comprising IgA derived from mature bovine milk and having specificity for at least one pathogen selected from the group consisting of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
A method for the prevention or treatment of otitis media comprising administering a composition comprising IgA derived from mature bovine milk and having specificity for at least one pathogen selected from the group consisting of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to an individual in need of same.
Mature bovine milk having a concentration of IgA of at least 1.5 μg/ml specific for at least one pathogen selected from the group consisting of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
A whey fraction produced from mature bovine milk having a concentration of IgA of at least 1.5 μg/ml specific for at least one pathogen selected from the group consisting of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Dependencies are inferred from the claim text.